4th Quarter - Report

ASSOCIATION FOR ACCESSIBLE MEDICINES for ASSOCIATION FOR ACCESSIBLE MEDICINES

Firm
Client
Income
—
Expenses
$539,634
Expense method
C: businesses, Internal Revenue Code section 162(e)

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Trade (domestic/foreign) TRD

Free Trade Agreements, including but not limited to: Colombia, Panama, and Korea Implementation of the Peru Trade Promotion Agreement Special 301 Report Any matters related to international activities with regard to access of generic medicines

LobbyistCovered position, as disclosed
KATHLEEN D JAEGER —
LISA LAYMAN —
JASON R MONEY —

Contacted: Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); Patent & Trademark Office (PTO); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); HOUSE OF REPRESENTATIVES; Treasury, Dept of; White House Office; SENATE; Federal Trade Commission (FTC); Commerce, Dept of (DOC); U.S. Trade Representative (USTR)

Copyright/Patent/Trademark CPT

Patent Reform, including but not limited to: S.1145, S.3600, and H.R.1908 Patent Settlements/Reverse Payments, including but not limited to: S.316, H.R.1432, and H.R.1902 Special 301 Report International Intellectual Property Issues Patent Process Issues, including but not limited to: S.3560, H.R.1778, and H.R.6344 Any other matter that relates to acess to generic drugs

LobbyistCovered position, as disclosed
KATHLEEN D JAEGER —
LISA LAYMAN —
JASON R MONEY —

Contacted: Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Food & Drug Administration (FDA); SENATE; U.S. Trade Representative (USTR); Commerce, Dept of (DOC); Federal Trade Commission (FTC); Health & Human Services, Dept of (HHS); Treasury, Dept of; White House Office

Bills named: H.R. 6344 (110th), S. 316 (110th), S. 3600 (110th), H.R. 1908 (110th), H.R. 1902 (110th), S. 1145 (110th), H.R. 1778 (110th), S. 3560 (110th), H.R. 1432 (110th)

Medicare/Medicaid MMM

Medicaid Reimbursement Medicaid Rebates The Deficit Reduction Act of 2006: all provisions relating to prescription drug reimbursement Any other matter that relates to access to generic drugs Average Manufacture Price (AMP)/AMP Publication such as H.R.6331

LobbyistCovered position, as disclosed
KATHLEEN D JAEGER —
LISA LAYMAN —
JASON R MONEY —

Contacted: Food & Drug Administration (FDA); SENATE; HOUSE OF REPRESENTATIVES; Federal Trade Commission (FTC); Commerce, Dept of (DOC); Patent & Trademark Office (PTO); Health & Human Services, Dept of (HHS); White House Office; Centers For Medicare and Medicaid Services (CMS); Treasury, Dept of; Congressional Budget Office (CBO); U.S. Trade Representative (USTR)

Bills named: H.R. 6331 (110th)

Budget/Appropriations BUD

FDA Congressional Appropriations, including but not limited to: H.R.2638 and H.R.2642 (Emergency Supplemental Bill) Generic Drug User Fees Funding for FDA, including but not limited to: any proposal relating to funding for the Office of Generic Drugs FY2009 and 2010 Presidential Budget Request

LobbyistCovered position, as disclosed
KATHLEEN D JAEGER —
LISA LAYMAN —
JASON R MONEY —

Contacted: Food & Drug Administration (FDA); SENATE; Federal Trade Commission (FTC); Treasury, Dept of; Patent & Trademark Office (PTO); Centers For Medicare and Medicaid Services (CMS); Commerce, Dept of (DOC); White House Office; U.S. Trade Representative (USTR); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO)

Bills named: H.R. 2642 (110th), H.R. 2638 (110th)

Pharmacy PHA

Generic Biologics, including but not limited to: S.623, S.1505, S.1695, H.R.1038, H.R.1956, and H.R.5629 Prescription Drug Safety Food and Drug Administration Act of 2007 (H.R.3580): any parts relating to access to generic drugs and the impact and marketing of prescription drugs Citizen Petitions, including but not limited to: S.25 and S.1088 Counterfeit Drugs/Import Safety/Pedigree including but not limited to: S.3409 and H.R.5839 Electronic Prescribing Authorized Generics including but not limited to: S.2408 and H.R.4296 Prescription Drug Importation/Re-Importation Any other matters that relate to access to generic drugs

LobbyistCovered position, as disclosed
KATHLEEN D JAEGER —
LISA LAYMAN —
JASON R MONEY —

Contacted: SENATE; Commerce, Dept of (DOC); Centers For Medicare and Medicaid Services (CMS); U.S. Trade Representative (USTR); Food & Drug Administration (FDA); Health & Human Services, Dept of (HHS); Congressional Budget Office (CBO); HOUSE OF REPRESENTATIVES; Patent & Trademark Office (PTO); Federal Trade Commission (FTC); White House Office; Treasury, Dept of

Bills named: S. 2408 (110th), H.R. 1038 (110th), S. 3409 (110th), H.R. 4296 (110th), H.R. 5839 (110th), S. 1695 (110th), S. 623 (110th), S. 25 (110th), S. 1505 (110th), S. 1088 (110th), H.R. 5629 (110th), H.R. 3580 (110th), H.R. 1956 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.